Circular RNAs Regulate Glucose Metabolism in Cancer Cells

References

• Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95. doi:10.1038/nrc2981
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Patel D, Gallagher AM, et al. Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data. Diabetologia. 2012;55(3):654–665. doi:10.1007/s00125-011-2390-3
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123(3191):309–314. doi:10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Warburg O. The chemical constitution of respiration ferment. Science. 1928;68(1767):437–443. doi:10.1126/science.68.1767.437
   PubMedGoogle Scholar
• Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519–530. doi:10.1085/jgp.8.6.519
   PubMedGoogle Scholar
• Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science. 2009;324(5930):1029–1033. doi:10.1126/science.1160809
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, et al., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis.
   Google Scholar
• Vander Heiden MG. Targeting cancer metabolism: a therapeutic window opens. Nat Rev Drug Discov. 2011;10(9):671–684. doi:10.1038/nrd3504
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Thompson CB. Cellular metabolism and disease: what do metabolic outliers teach us? Cell. 2012;148(6):1132–1144. doi:10.1016/j.cell.2012.02.032
   PubMed Web of Science ®Google Scholar
• Lunt SY, Vander Heiden MG. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu Rev Cell Dev Biol. 2011;27(1):441–464. doi:10.1146/annurev-cellbio-092910-154237
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu Y, Wang Y, et al. Bacillus amyloliquefaciens SC06 alleviates the oxidative stress of IPEC-1 via modulating Nrf2/Keap1 signaling pathway and decreasing ROS production. Appl Microbiol Biotechnol. 2017;101(7):3015–3026. doi:10.1007/s00253-016-8032-4
   PubMed Web of Science ®Google Scholar
• Held-Warmkessel J, Dell DD. Lactic acidosis in patients with cancer. Clin J Oncol Nurs. 2014;18(5):592–594. doi:10.1188/14.CJON.592-594
   PubMed Web of Science ®Google Scholar
• Peppicelli S, Bianchini F, Calorini L. Extracellular acidity a “Reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy. Cancer Metastasis Rev. 2014;33(2–3):823–832.
   PubMed Web of Science ®Google Scholar
• Shiraishi T, Verdone JE, Huang J, et al. Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells. Oncotarget. 2015;6(1):130–143. doi:10.18632/oncotarget.2766
   PubMedGoogle Scholar
• Sanger HL, Klotz G, Riesner D, et al. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc Natl Acad Sci U S A. 1976;73(11):3852–3856. doi:10.1073/pnas.73.11.3852
   PubMed Web of Science ®Google Scholar
• Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature. 1979;280(5720):339–340. doi:10.1038/280339a0
   PubMed Web of Science ®Google Scholar
• Salzman J, Gawad C, Wang PL, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One. 2012;7(2):e30733. doi:10.1371/journal.pone.0030733
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sorrentino JA, Wang K, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19(2):141–157. doi:10.1261/rna.035667.112
   PubMed Web of Science ®Google Scholar
• Du WW, Fang L, Yang W, et al. Induction of tumor apoptosis through a circular RNA enhancing Foxo3 activity. Cell Death Differ. 2017;24(2):357–370. doi:10.1038/cdd.2016.133
   PubMed Web of Science ®Google Scholar
• Abbaszadeh-Goudarzi K, Radbakhsh S, Pourhanifeh MH, et al. Circular RNA and diabetes: epigenetic regulator with diagnostic role. Curr Mol Med. 2020;20(7):516–526. doi:10.2174/1566524020666200129142106
   PubMed Web of Science ®Google Scholar
• Armakola M, Higgins MJ, Figley MD, et al. Inhibition of RNA lariat debranching enzyme suppresses TDP-43 toxicity in ALS disease models. Nat Genet. 2012;44(12):1302–1309. doi:10.1038/ng.2434
   PubMed Web of Science ®Google Scholar
• Borran S, Ahmadi G, Rezaei S, et al. Circular RNAs: new players in thyroid cancer. Pathol Res Pract. 2020;216(10):153217. doi:10.1016/j.prp.2020.153217
   PubMed Web of Science ®Google Scholar
• Li Z, Huang C, Bao C, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256–264. doi:10.1038/nsmb.2959
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang X-O, Chen T, et al. Circular intronic long noncoding RNAs. Mol Cell. 2013;51(6):792–806. doi:10.1016/j.molcel.2013.08.017
   PubMed Web of Science ®Google Scholar
• Xu H, Guo S, Li W, et al. The circular RNA Cdr1as, via miR-7 and its targets, regulates insulin transcription and secretion in islet cells. Sci Rep. 2015;5(1):12453. doi:10.1038/srep12453
   PubMedGoogle Scholar
• Li F, Zhang L, Li W, et al. Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway. Oncotarget. 2015;6(8):6001–6013. doi:10.18632/oncotarget.3469
   PubMed Web of Science ®Google Scholar
• Ashwal-Fluss R, Meyer M, Pamudurti N, et al. circRNA biogenesis competes with pre-mRNA splicing. Mol Cell. 2014;56(1):55–66. doi:10.1016/j.molcel.2014.08.019
   PubMed Web of Science ®Google Scholar
• Nahand JS, Jamshidi S, Hamblin MR, et al. Circular RNAs: new epigenetic signatures in viral infections. Front Microbiol. 2020;11:1853. doi:10.3389/fmicb.2020.01853
   PubMed Web of Science ®Google Scholar
• Du WW, Yang W, Liu E, et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44(6):2846–2858. doi:10.1093/nar/gkw027
   PubMed Web of Science ®Google Scholar
• Memczak S, Jens M, Elefsinioti A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495(7441):333–338. doi:10.1038/nature11928
   PubMed Web of Science ®Google Scholar
• Hansen TB, Jensen TI, Clausen BH, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384–388. doi:10.1038/nature11993
   PubMed Web of Science ®Google Scholar
• Shabaninejad Z, Vafadar A, Movahedpour A, et al. Circular RNAs in cancer: new insights into functions and implications in ovarian cancer. J Ovarian Res. 2019;12(1):84. doi:10.1186/s13048-019-0558-5
   PubMed Web of Science ®Google Scholar
• Zhao M, Fan J, Liu Y, et al. Oncogenic role of the TP53-induced glycolysis and apoptosis regulator in nasopharyngeal carcinoma through NF-κB pathway modulation. Int J Oncol. 2016;48(2):756–764. doi:10.3892/ijo.2015.3297
   PubMed Web of Science ®Google Scholar
• Faubert B, Vincent EE, Griss T, et al. Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1alpha. Proc Natl Acad Sci U S A. 2014;111(7):2554–2559. doi:10.1073/pnas.1312570111
   PubMed Web of Science ®Google Scholar
• Mirzaei H, Hamblin MR. Regulation of glycolysis by non-coding rnas in cancer: switching on the Warburg effect. Mol Ther Oncolytics. 2020;19:218–239.
   PubMed Web of Science ®Google Scholar
• Panisova E, Kery M, Kopacek J, et al. Enhanced metabolism as a common feature of cancer plasticity. Neoplasma. 2016;63(6):836–845. doi:10.4149/neo_2016_602
   PubMed Web of Science ®Google Scholar
• Mueckler M, Thorens B. The SLC2 (GLUT) family of membrane transporters. Mol Aspects Med. 2013;34(2–3):121–138. doi:10.1016/j.mam.2012.07.001
   PubMed Web of Science ®Google Scholar
• Fan C, Tang Y, Wang J, et al. Role of long non-coding RNAs in glucose metabolism in cancer. Mol Cancer. 2017;16(1):130. doi:10.1186/s12943-017-0699-3
   PubMedGoogle Scholar
• Greco M, Crippa F, Agresti R, et al. Axillary lymph node staging in breast cancer by 2-fluoro-2-deoxy-D-glucose-positron emission tomography: clinical evaluation and alternative management. J Natl Cancer Inst. 2001;93(8):630–635. doi:10.1093/jnci/93.8.630
   PubMedGoogle Scholar
• Chen X, Yu J, Tian H, et al. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis. J Cell Physiol. 2019;234(11):19130–19140. doi:10.1002/jcp.28692
   PubMed Web of Science ®Google Scholar
• Qi C, Qin X, Zhou Z, et al. Circ_0072995 promotes cell carcinogenesis via up-regulating miR-149-5p-mediated SHMT2 in breast cancer. Cancer Manag Res. 2020;12:11169–11181. doi:10.2147/CMAR.S272274
   PubMed Web of Science ®Google Scholar
• Ding DY, Wang D, Shu ZB. Hsa_circ_0007534 knockdown represses the development of colorectal cancer cells through regulating miR-613/SLC25A22 axis. Eur Rev Med Pharmacol Sci. 2021;25(2):570.
   PubMed Web of Science ®Google Scholar
• Chidambaran V, Costandi A, D’Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015;29(7):543–563.
   PubMed Web of Science ®Google Scholar
• Oren-Ziv A, Hoppenstein D, Shles A, et al. Sedation methods for intra-articular corticosteroid injections in Juvenile Idiopathic Arthritis: a review. Pediatr Rheumatol Online J. 2015;13(1):28. doi:10.1186/s12969-015-0021-0
   PubMedGoogle Scholar
• Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2020;Volume 13(3):5293–5307. doi:10.1080/08923970701675085
   Google Scholar
• Song J, et al. Mini profile of potential anticancer properties of propofol. PLoS One. 2021;19(1):e114440. doi:10.1371/journal.pone.0114440
   Google Scholar
• Yu B, et al. Propofol induces apoptosis of breast cancer cells by downregulation of miR-24 signal pathway. Cancer Biomark. 2018;21(3):513–519. doi:10.3233/CBM-170234
   PubMed Web of Science ®Google Scholar
• Zhang W, et al. Propofol inhibits proliferation, migration and invasion of gastric cancer cells by up-regulating microRNA-195. Int J Biol Macromol. 2018;120(Pt A):975–984. doi:10.1016/j.ijbiomac.2018.08.173
   PubMedGoogle Scholar
• Zhao H, Wei H, He J, et al. Propofol disrupts cell carcinogenesis and aerobic glycolysis by regulating circTADA2A/miR-455-3p/FOXM1 axis in lung cancer. Cell Cycle. 2020;19(19):2538–2552. doi:10.1080/15384101.2020.1810393
   PubMed Web of Science ®Google Scholar
• Xiong S, et al. Circular RNA MYLK promotes glycolysis and proliferation of non-small cell lung cancer cells by sponging miR-195-5p and increasing glucose transporter Member 3 expression. Cancer Manag Res. 2020;19:5469–5478. doi:10.2147/CMAR.S257386
   Google Scholar
• Tan VP, Miyamoto S. HK2/hexokinase-II integrates glycolysis and autophagy to confer cellular protection. Autophagy. 2015;11(6):963–964. doi:10.1080/15548627.2015.1042195
   PubMed Web of Science ®Google Scholar
• Heneberg P. Redox Regulation of Hexokinases. Antioxid Redox Signal. 2019;30(3):415–442. doi:10.1089/ars.2017.7255
   PubMed Web of Science ®Google Scholar
• Zhu X, Du J, Gu Z. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma. Mol Cell Biochem. 2020;474(1–2):147–158. doi:10.1007/s11010-020-03840-5
   PubMed Web of Science ®Google Scholar
• Liu Z, Liu F, Wang F, et al. CircZNF609 promotes cell proliferation, migration, invasion, and glycolysis in nasopharyngeal carcinoma through regulating HRAS via miR-338-3p. Mol Cell Biochem. 2021;476(1):175–186. doi:10.1007/s11010-020-03894-5
   PubMed Web of Science ®Google Scholar
• Du S, et al. Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p/HK2 axis. Cancer Manag Res. 2020;12:7487–7499. doi:10.2147/CMAR.S257441
   PubMed Web of Science ®Google Scholar
• Cao L, et al. Circular RNA circRNF20 promotes breast cancer tumorigenesis and Warburg effect through miR-487a/HIF-1α/HK2. Cell Death Dis. 2020;11(2):145. doi:10.1038/s41419-020-2336-0
   PubMed Web of Science ®Google Scholar
• Ding C, Wu Z, You H, et al. CircNFIX promotes progression of glioma through regulating miR-378e/RPN2 axis. J Exp Clin Cancer Res. 2019;38(1):506. doi:10.1186/s13046-019-1483-6
   PubMed Web of Science ®Google Scholar
• Li Q, et al. Yeast two-hybrid screening identified WDR77 as a novel interacting partner of TSC22D2. Tumour Biol. 2016;37(9):12503–12512. doi:10.1007/s13277-016-5113-z
   PubMedGoogle Scholar
• Liang F, et al. TSC22D2 interacts with PKM2 and inhibits cell growth in colorectal cancer. Int J Oncol. 2016;49(3):1046–1056. doi:10.3892/ijo.2016.3599
   PubMed Web of Science ®Google Scholar
• Li Q, Pan X, Zhu D, et al. Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress. Hepatology. 2019;70(4):1298–1316. doi:10.1002/hep.30671
   PubMed Web of Science ®Google Scholar
• Xie ZF, et al. Circular RNA hsa_circ_0006168 contributes to cell proliferation, migration and invasion in esophageal cancer by regulating miR-384/RBBP7 axis via activation of S6K/S6 pathway. Eur Rev Med Pharmacol Sci. 2020;24(1):151–163. doi:10.26355/eurrev_202001_19906
   PubMed Web of Science ®Google Scholar
• Hou W, Zhang Y. Circ_0025033 promotes the progression of ovarian cancer by activating the expression of LSM4 via targeting miR-184. Pathol Res Pract. 2021;217:153275. doi:10.1016/j.prp.2020.153275
   PubMed Web of Science ®Google Scholar
• Dang CV, Le A, Gao P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479–6483. doi:10.1158/1078-0432.CCR-09-0889
   PubMed Web of Science ®Google Scholar
• Wulaningsih W, et al. Serum lactate dehydrogenase and survival following cancer diagnosis. Br J Cancer. 2015;113(9):1389–1396. doi:10.1038/bjc.2015.361
   PubMed Web of Science ®Google Scholar
• Fukumura D, Xu L, Chen Y, et al. Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. Cancer Res. 2001;61(16):6020–6024.
   PubMed Web of Science ®Google Scholar
• Hirschhaeuser F, Sattler UG, Mueller-Klieser W. Lactate: a metabolic key player in cancer. Cancer Res. 2011;71(22):6921–6925. doi:10.1158/0008-5472.CAN-11-1457
   PubMed Web of Science ®Google Scholar
• Long N, et al. CircPOSTN/miR-361-5p/TPX2 axis regulates cell growth, apoptosis and aerobic glycolysis in glioma cells. Cancer Cell Int. 2020;20:374. doi:10.1186/s12935-020-01454-x
   PubMed Web of Science ®Google Scholar
• Zhao Y, et al. Circle RNA circABCB10 modulates PFN2 to promote breast cancer progression, as well as aggravate radioresistance through facilitating glycolytic metabolism via miR-223-3p. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3389
   Web of Science ®Google Scholar
• Patel MS, Korotchkina LG. Regulation of the pyruvate dehydrogenase complex. Biochem Soc Trans. 2006;34(Pt 2):217–222. doi:10.1042/BST0340217
   PubMedGoogle Scholar
• Gudi R, et al. Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 1995;270(48):28989–28994. doi:10.1074/jbc.270.48.28989
   PubMed Web of Science ®Google Scholar
• Sugden MC, Holness MJ. Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB j. 1994;8(1):54–61. doi:10.1096/fasebj.8.1.8299890
   PubMed Web of Science ®Google Scholar
• Hu R, Chen S, Yan J. Blocking circ-CNST suppresses malignant behaviors of osteosarcoma cells and inhibits glycolysis through circ-CNST-miR-578-LDHA/PDK1 ceRNA networks. J Orthop Surg Res. 2021;16(1):300. doi:10.1186/s13018-021-02427-0
   PubMed Web of Science ®Google Scholar
• Xie W, et al. Circ_0002711 knockdown suppresses cell growth and aerobic glycolysis by modulating miR-1244/ROCK1 axis in ovarian cancer. J Biosci. 2021;46:1.
   PubMed Web of Science ®Google Scholar
• Jin C, et al. CircRNA EPHB4 modulates stem properties and proliferation of gliomas via sponging miR-637 and up-regulating SOX10. Mol Oncol. 2021;15(2):596–622. doi:10.1002/1878-0261.12830
   PubMed Web of Science ®Google Scholar
• Shu J, Du J, Wang F, et al. Circ_0091579 enhances the malignancy of hepatocellular carcinoma via miR-1287/PDK2 axis. Open Life Sci. 2021;16(1):69–83. doi:10.1515/biol-2021-0009
   PubMed Web of Science ®Google Scholar
• Ren H, Song Z, Chao C, et al. circCCDC66 promotes thyroid cancer cell proliferation, migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis. Oncol Lett. 2021;21(5):416. doi:10.3892/ol.2021.12677
   PubMed Web of Science ®Google Scholar
• Kelly B, O’Neill LA. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 2015;25(7):771–784. doi:10.1038/cr.2015.68
   PubMed Web of Science ®Google Scholar
• Masui K, Tanaka K, Akhavan D, et al. mTOR complex 2 controls glycolytic metabolism in glioblastoma through FoxO acetylation and upregulation of c-Myc. Cell Metab. 2013;18(5):726–739. doi:10.1016/j.cmet.2013.09.013
   PubMed Web of Science ®Google Scholar
• Kim J-W, Gao P, Liu Y-C, et al. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27(21):7381–7393. doi:10.1128/MCB.00440-07
   PubMed Web of Science ®Google Scholar
• Sullivan WJ, Mullen PJ, Schmid EW, et al. Extracellular matrix remodeling regulates glucose metabolism through TXNIP destabilization. Cell. 2018;175(1):117–132.e21. doi:10.1016/j.cell.2018.08.017
   PubMed Web of Science ®Google Scholar
• Shen S, Yao T, Xu Y, et al. CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc. Mol Cancer. 2020;19(1):151. doi:10.1186/s12943-020-01269-4
   PubMed Web of Science ®Google Scholar
• Wu W, Xi W, Li H, et al. Circular RNA circ‑ACACA regulates proliferation, migration and glycolysis in non‑small‑cell lung carcinoma via miR‑1183 and PI3K/PKB pathway. Int J Mol Med. 2020;45(6):1814–1824. doi:10.3892/ijmm.2020.4549
   PubMed Web of Science ®Google Scholar
• Qian X, Xu W, Xu J, et al. Enolase 1 stimulates glycolysis to promote chemoresistance in gastric cancer. Oncotarget. 2017;8(29):47691–47708. doi:10.18632/oncotarget.17868
   PubMedGoogle Scholar
• Capello M, Ferri-Borgogno S, Riganti C, et al. Targeting the Warburg effect in cancer cells through ENO1 knockdown rescues oxidative phosphorylation and induces growth arrest. Oncotarget. 2016;7(5):5598–5612. doi:10.18632/oncotarget.6798
   PubMedGoogle Scholar
• Chen S, Zhang Y, Wang H, et al. WW domain-binding protein 2 acts as an oncogene by modulating the activity of the glycolytic enzyme ENO1 in glioma. Cell Death Dis. 2018;9(3):347. doi:10.1038/s41419-018-0376-5
   PubMedGoogle Scholar
• Zhou J, Zhang S, Chen Z, et al. CircRNA-ENO1 promoted glycolysis and tumor progression in lung adenocarcinoma through upregulating its host gene ENO1. Cell Death Dis. 2019;10(12):885. doi:10.1038/s41419-019-2127-7
   PubMedGoogle Scholar
• Zdralevic M, Marchiq I, de Padua MMC, et al. Metabolic plasiticy in cancers-distinct role of glycolytic enzymes GPI, LDHs or membrane transporters MCTs. Front Oncol. 2017;7:313. doi:10.3389/fonc.2017.00313
   PubMed Web of Science ®Google Scholar
• Li X, Jiang Y, Meisenhelder J, et al. Mitochondria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Mol Cell. 2016;61(5):705–719. doi:10.1016/j.molcel.2016.02.009
   PubMed Web of Science ®Google Scholar
• Li H, Yang F, Hu A, et al. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression. EMBO Mol Med. 2019;11(12):e10835. doi:10.15252/emmm.201910835
   PubMed Web of Science ®Google Scholar
• Maxwell PH, Pugh CW, Ratcliffe PJ. Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001;11(3):293–299. doi:10.1016/S0959-437X(00)00193-3
   PubMed Web of Science ®Google Scholar
• Starska K, Forma E, Jóźwiak P, et al. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer-the relationship with regulatory hypoxia-inducible factor-1alpha expression, tumor invasiveness, and patient prognosis. Tumour Biol. 2015;36(4):2309–2321. doi:10.1007/s13277-014-2838-4
   PubMedGoogle Scholar
• Iyer NV, Kotch LE, Agani F, et al. Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12(2):149–162. doi:10.1101/gad.12.2.149
   PubMed Web of Science ®Google Scholar
• Hussien R, Brooks GA. Mitochondrial and plasma membrane lactate transporter and lactate dehydrogenase isoform expression in breast cancer cell lines. Physiol Genomics. 2011;43(5):255–264. doi:10.1152/physiolgenomics.00177.2010
   PubMed Web of Science ®Google Scholar
• Kim J-W, Tchernyshyov I, Semenza GL, et al. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177–185. doi:10.1016/j.cmet.2006.02.002
   PubMed Web of Science ®Google Scholar
• Hayashi M, et al. Induction of glucose transporter 1 expression through hypoxia-inducible factor 1α under hypoxic conditions in trophoblast-derived cells. J Endocrinol. 2017;8(29):47691–47708. doi:10.1677/joe.1.05599
   Google Scholar
• Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO j. 1998;17(11):3005–3015.
   PubMed Web of Science ®Google Scholar
• Liang G, Liu Z, Tan L, et al. HIF1alpha-associated circDENND4C promotes proliferation of breast cancer cells in hypoxic environment. Anticancer Res. 2017;37(8):4337–4343. doi:10.21873/anticanres.11827
   PubMed Web of Science ®Google Scholar
• Xu G, et al. Circular RNA circNRIP1 Sponges microRNA-138-5p to maintain hypoxia-induced resistance to 5-fluorouracil through HIF-1α-dependent glucose metabolism in gastric carcinoma. Cancer Manag Res. 2020;12:2789–2802. doi:10.2147/CMAR.S246272
   PubMed Web of Science ®Google Scholar
• Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387–398. doi:10.1038/nrc2389
   PubMed Web of Science ®Google Scholar
• Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature. 2005;434(7035):843–850. doi:10.1038/nature03319
   PubMed Web of Science ®Google Scholar
• Bagherian A, Mardani R, Roudi B, et al. Combination therapy with nanomicellar-curcumin and temozolomide for in vitro therapy of glioblastoma multiforme via Wnt signaling pathways. J Mol Neurosci. 2020;70(10):1471–1483. doi:10.1007/s12031-020-01639-z
   PubMed Web of Science ®Google Scholar
• Yousefi F, Shabaninejad Z, Vakili S, et al. TGF-β and WNT signaling pathways in cardiac fibrosis: non-coding RNAs come into focus. Cell Commun Signal. 2020;18(1):87. doi:10.1186/s12964-020-00555-4
   PubMed Web of Science ®Google Scholar
• Ghasemi F, Shafiee M, Banikazemi Z, et al. Curcumin inhibits NF-kB and Wnt/β-catenin pathways in cervical cancer cells. Pathol Res Pract. 2019;215(10):152556. doi:10.1016/j.prp.2019.152556
   PubMed Web of Science ®Google Scholar
• Halldorsson S, Rohatgi N, Magnusdottir M, et al. Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition. Cancer Lett. 2017;396:117–129. doi:10.1016/j.canlet.2017.03.019
   PubMed Web of Science ®Google Scholar
• Lunetti P, Di Giacomo M, Vergara D, et al. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes. Febs j. 2019;286(4):688–709. doi:10.1111/febs.14756
   PubMed Web of Science ®Google Scholar
• Peppicelli S, Toti A, Giannoni E, et al. Metformin is also effective on lactic acidosis-exposed melanoma cells switched to oxidative phosphorylation. Cell Cycle. 2016;15(14):1908–1918. doi:10.1080/15384101.2016.1191706
   PubMed Web of Science ®Google Scholar
• Lee SY, Jeon HM, Ju MK, et al. Wnt/Snail signaling regulates cytochrome C oxidase and glucose metabolism. Cancer Res. 2012;72(14):3607–3617. doi:10.1158/0008-5472.CAN-12-0006
   PubMed Web of Science ®Google Scholar
• Liu G-M, Li Q, Zhang P-F, et al. Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma. Cell Death Dis. 2018;9(11):1132. doi:10.1038/s41419-018-1165-x
   PubMed Web of Science ®Google Scholar
• Pan Z, Cai J, Lin J, et al. A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer. Mol Cancer. 2020;19(1):71. doi:10.1186/s12943-020-01179-5
   PubMed Web of Science ®Google Scholar
• Han L, Cheng J, Li A. hsa_circ_0072387 suppresses proliferation, metastasis, and glycolysis of oral squamous cell carcinoma cells by downregulating miR-503-5p. Cancer Biother Radiopharm. 2021;36(1):84–94. doi:10.1089/cbr.2019.3371
   PubMed Web of Science ®Google Scholar
• Gottlob K, et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev. 2001;15(11):1406–1418. doi:10.1101/gad.889901
   PubMed Web of Science ®Google Scholar
• van Dam EM, Govers R, James DE. Akt activation is required at a late stage of insulin-induced GLUT4 translocation to the plasma membrane. Mol Endocrinol. 2005;19(4):1067–1077. doi:10.1210/me.2004-0413
   PubMedGoogle Scholar
• Salani B, Ravera S, Amaro A, et al. IGF1 regulates PKM2 function through Akt phosphorylation. Cell Cycle. 2015;14(10):1559–1567. doi:10.1080/15384101.2015.1026490
   PubMed Web of Science ®Google Scholar
• Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002;13(10):444–451. doi:10.1016/S1043-2760(02)00662-8
   PubMed Web of Science ®Google Scholar
• Miyamoto S, Murphy AN, Brown JH. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008;15(3):521–529. doi:10.1038/sj.cdd.4402285
   PubMed Web of Science ®Google Scholar
• Robey RB, Hay N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene. 2006;25(34):4683–4696. doi:10.1038/sj.onc.1209595
   PubMed Web of Science ®Google Scholar
• Majumder PK, Febbo PG, Bikoff R, et al. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. Nat Med. 2004;10(6):594–601. doi:10.1038/nm1052
   PubMed Web of Science ®Google Scholar
• Skeen JE, Bhaskar PT, Chen -C-C, et al. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner. Cancer Cell. 2006;10(4):269–280. doi:10.1016/j.ccr.2006.08.022
   PubMed Web of Science ®Google Scholar
• Gu F, Zhang J, Yan L, et al. CircHIPK3/miR-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the AKT/mTOR signaling pathway. Open Life Sci. 2020;15(1):683–695. doi:10.1515/biol-2020-0070
   PubMed Web of Science ®Google Scholar
• Yalan S, Yanfang L, He C, et al. Circular RNA circRHOBTB3 inhibits ovarian cancer progression through PI3K/AKT signaling pathway. Panminerva Med. 2020. doi:10.23736/S0031-0808.20.03957-9
   PubMed Web of Science ®Google Scholar
• Vander Heiden MG, Lunt SY, Dayton TL, et al. Metabolic pathway alterations that support cell proliferation. Cold Spring Harb Symp Quant Biol. 2011;76:325–334. doi:10.1101/sqb.2012.76.010900
   PubMedGoogle Scholar
• Wolf A, Agnihotri S, Micallef J, et al. Hexokinase 2 is a key mediator of aerobic glycolysis and promotes tumor growth in human glioblastoma multiforme. J Exp Med. 2011;208(2):313–326. doi:10.1084/jem.20101470
   PubMed Web of Science ®Google Scholar
• Bluemlein K, Grüning N-M, Feichtinger RG, et al. No evidence for a shift in pyruvate kinase PKM1 to PKM2 expression during tumorigenesis. Oncotarget. 2011;2(5):393–400. doi:10.18632/oncotarget.278
   PubMedGoogle Scholar
• Chan DA, Sutphin PD, Nguyen P, et al. Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011;3(94):94ra70. doi:10.1126/scitranslmed.3002394
   PubMed Web of Science ®Google Scholar
• Le A, Cooper CR, Gouw AM, et al. Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A. 2010;107(5):2037–2042. doi:10.1073/pnas.0914433107
   PubMed Web of Science ®Google Scholar
• Janssen HLA, Reesink HW, Lawitz EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med. 2013;368(18):1685–1694. doi:10.1056/NEJMoa1209026
   PubMed Web of Science ®Google Scholar
• Pusapati RV, Daemen A, Wilson C, et al. mTORC1-dependent metabolic reprogramming underlies escape from glycolysis addiction in cancer cells. Cancer Cell. 2016;29(4):548–562. doi:10.1016/j.ccell.2016.02.018
   PubMed Web of Science ®Google Scholar
• Fodor T, Szántó M, Abdul-Rahman O, et al. Combined treatment of MCF-7 cells with AICAR and methotrexate, arrests cell cycle and reverses warburg metabolism through AMP-Activated Protein Kinase (AMPK) and FOXO1. PLoS One. 2016;11(2):e0150232. doi:10.1371/journal.pone.0150232
   PubMed Web of Science ®Google Scholar
• Baysal BE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287(5454):848–851. doi:10.1126/science.287.5454.848
   PubMed Web of Science ®Google Scholar
• Ben-Haim S, Ell P. 18F-FDG PET and PET/CT in the evaluation of cancer treatment response. J Nucl Med. 2009;50(1):88–99. doi:10.2967/jnumed.108.054205
   PubMed Web of Science ®Google Scholar
• Folger O, Jerby L, Frezza C, et al. Predicting selective drug targets in cancer through metabolic networks. Mol Syst Biol. 2011;7(1):501. doi:10.1038/msb.2011.35
   PubMedGoogle Scholar
• Frezza C, Zheng L, Folger O, et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature. 2011;477(7363):225–228. doi:10.1038/nature10363
   PubMed Web of Science ®Google Scholar
• Agren R, Mardinoglu A, Asplund A, et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol. 2014;10(3):721. doi:10.1002/msb.145122
   PubMed Web of Science ®Google Scholar
• Yi G, Wang D, Han J, et al. circKLHL24 blocks breast cancer development by regulating the miR-1204/ALX4 Network. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2020.3992
   PubMed Web of Science ®Google Scholar
• Li C, Liu H, Niu Q, et al. Circ_0000376, a Novel circRNA, promotes the progression of non-small cell lung cancer through regulating the miR-1182/NOVA2 network. Cancer Manag Res. 2020;12:7635–7647. doi:10.2147/CMAR.S258340
   PubMedGoogle Scholar
• Ma J, Qi G, Li L, Novel Serum A. Exosomes-based biomarker hsa_circ_0002130 facilitates osimertinib-resistance in non-small cell lung cancer by sponging miR-498. Onco Targets Ther. 2020;13:5293–5307. doi:10.2147/OTT.S243214
   PubMed Web of Science ®Google Scholar
• Dong W, Zhao L, Zhang S, et al. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis. World J Surg Oncol. 2021;19(1):75. doi:10.1186/s12957-021-02184-8
   PubMed Web of Science ®Google Scholar
• Guo J, Su Y, Zhang M. Circ_0000140 restrains the proliferation, metastasis and glycolysis metabolism of oral squamous cell carcinoma through upregulating CDC73 via sponging miR-182-5p. Cancer Cell Int. 2020;20(1):407. doi:10.1186/s12935-020-01501-7
   PubMed Web of Science ®Google Scholar
• Hu B, Xian Z, Zou Q, et al. CircFAT1 Suppresses Colorectal Cancer Development Through Regulating miR-520b/UHRF1 Axis or miR-302c-3p/UHRF1 Axis. Cancer Biother Radiopharm. 2021;36(1):45–57. doi:10.1089/cbr.2019.3291
   PubMed Web of Science ®Google Scholar
• Zhang ZJ, Zhang Y-H, Qin X-J, et al. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis. Eur Rev Med Pharmacol Sci. 2020;24(5):2387–2400. doi:10.26355/eurrev_202003_20506
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang S, Lin G, et al. Down-regulation of circ-PTN suppresses cell proliferation, invasion and glycolysis in glioma by regulating miR-432-5p/RAB10 axis. Neurosci Lett. 2020;735:135153. doi:10.1016/j.neulet.2020.135153
   PubMed Web of Science ®Google Scholar
• Chen Y, et al. Silencing of circular RNA circPDE5A suppresses neuroblastoma progression by targeting the miR-362-5p/NOL4L axis. Int J Neurosci. 2021:1–11.
   PubMed Web of Science ®Google Scholar
• Liu J, Li X, Yue L, et al. Circ_0105346 knockdown inhibits osteosarcoma development via regulating miR-1182/WNT7B axis. Cancer Manag Res. 2021;13:521–535. doi:10.2147/CMAR.S281430
   PubMed Web of Science ®Google Scholar
• Chen W, Li Y, Zhong J, et al. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Mol Med Rep. 2021;23(6):6. doi:10.3892/mmr.2021.12103
   PubMed Web of Science ®Google Scholar
• Peng L, Chen G, Zhu Z, et al. Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung’s disease. Oncotarget. 2017;8(1):808–818. doi:10.18632/oncotarget.13656
   PubMedGoogle Scholar
• Qiu L, Zheng L, Gan C, et al. circBICD2 targets miR-149-5p/IGF2BP1 axis to regulate oral squamous cell carcinoma progression. J Oral Pathol Med. 2020. doi:10.1111/jop.13156
   PubMed Web of Science ®Google Scholar
• Zheng Z, Ma X, Li H. Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2. J Cell Mol Med. 2020;24(13):7531–7537. doi:10.1111/jcmm.15380
   PubMed Web of Science ®Google Scholar
• Xing Z, Wang X, Liu J, et al. Hsa_circ_0069094 accelerates cell malignancy and glycolysis through regulating the miR-591/HK2 axis in breast cancer. Cell Signal. 2021;79:109878. doi:10.1016/j.cellsig.2020.109878
   PubMed Web of Science ®Google Scholar
• Dou D, Ren X, Han M, et al. Circ_0008039 supports breast cancer cell proliferation, migration, invasion, and glycolysis by regulating the miR-140-3p/SKA2 axis. Mol Oncol. 2021;15(2):697–709. doi:10.1002/1878-0261.12862
   PubMed Web of Science ®Google Scholar
• Zang H, Li Y, Zhang X, et al. Knockdown of circRAD18 Mitigates Breast Cancer Progression through the Regulation of miR-613/HK2 Axis. Cancer Manag Res. 2020;12:3661–3672. doi:10.2147/CMAR.S243300
   PubMed Web of Science ®Google Scholar
• Lu J, Zhu Y, Qin Y, et al. CircNFIX Acts as a miR-212-3p sponge to enhance the malignant progression of non-small cell lung cancer by up-regulating ADAM10. Cancer Manag Res. 2020;12:9577–9587. doi:10.2147/CMAR.S272309
   PubMed Web of Science ®Google Scholar
• Shi Q, Ji T, Ma Z, et al. Serum exosomes-based biomarker circ_0008928 regulates cisplatin sensitivity, tumor progression, and glycolysis metabolism by miR-488/HK2 axis in cisplatin-resistant nonsmall cell lung carcinoma. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2020.4490
   Web of Science ®Google Scholar
• Ding Z, Guo L, Deng Z, et al. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis. Ann Hepatol. 2020;19(3):269–279. doi:10.1016/j.aohep.2020.01.002
   PubMed Web of Science ®Google Scholar
• Fang Q, Liu H, Zhou A, et al. Circ_0046599 promotes the development of hepatocellular carcinoma by regulating the miR-1258/RPN2 network. Cancer Manag Res. 2020;12:6849–6860. doi:10.2147/CMAR.S253510
   PubMed Web of Science ®Google Scholar
• Li Y, Zang H, Zhang X, et al. Exosomal Circ-ZNF652 promotes cell proliferation, migration, invasion and glycolysis in hepatocellular carcinoma via miR-29a-3p/GUCD1 axis. Cancer Manag Res. 2020;12:7739–7751. doi:10.2147/CMAR.S259424
   PubMed Web of Science ®Google Scholar
• Liu W, Yin C, Liu Y. Circular RNA circ_0091579 promotes hepatocellular carcinoma proliferation, migration, invasion, and glycolysis through miR-490-5p/CASC3 axis. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3472
   Web of Science ®Google Scholar
• Liu Y, Li R, Wang X, et al. CircTTBK2 contributes to the progression of glioma through regulating miR-145-5p/CPEB4 axis. Cancer Manag Res. 2020;12:8183–8195. doi:10.2147/CMAR.S263586
   PubMed Web of Science ®Google Scholar
• Zhang K, Hu H, Xu J, et al. Circ_0001421 facilitates glycolysis and lung cancer development by regulating miR-4677-3p/CDCA3. Diagn Pathol. 2020;15(1):133. doi:10.1186/s13000-020-01048-1
   PubMed Web of Science ®Google Scholar
• Che H, Ding H, Jia X. circ_0080145 enhances imatinib resistance of chronic myeloid leukemia by regulating miR-326/PPFIA1 axis. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2020.3600
   Web of Science ®Google Scholar
• Jia Y, Liu M, Wang S. CircRNA hsa_circRNA_0001776 inhibits proliferation and promotes apoptosis in endometrial cancer via downregulating LRIG2 by sponging miR-182. Cancer Cell Int. 2020;20(1):412. doi:10.1186/s12935-020-01437-y
   PubMed Web of Science ®Google Scholar
• Fang X, Bai Y, Zhang L, et al. Silencing circSLAMF6 represses cell glycolysis, migration, and invasion by regulating the miR-204-5p/MYH9 axis in gastric cancer under hypoxia. Biosci Rep. 2020;40(6):6. doi:10.1042/BSR20201275
   Google Scholar
• Li Z, Fu Y, Ouyang W, et al. Circ_0016347 promotes osteosarcoma progression by regulating miR-1225-3p/KCNH1 axis. Cancer Biother Radiopharm. 2021. doi:10.1089/cbr.2019.3349
   Web of Science ®Google Scholar
• Zhang Y, Zhao L, Yang S, et al. CircCDKN2B-AS1 interacts with IMP3 to stabilize hexokinase 2 mRNA and facilitate cervical squamous cell carcinoma aerobic glycolysis progression. J Exp Clin Cancer Res. 2020;39(1):281. doi:10.1186/s13046-020-01793-7
   PubMed Web of Science ®Google Scholar
• Zhang Y, Shi Z, Li Z, et al. Circ_0057553/miR-515-5p regulates prostate cancer cell proliferation, apoptosis, migration, invasion and aerobic glycolysis by targeting YES1. Onco Targets Ther. 2020;13:11289–11299. doi:10.2147/OTT.S272294
   PubMed Web of Science ®Google Scholar
• Tian S, Han G, Lu L, et al. Circ-FOXM1 contributes to cell proliferation, invasion, and glycolysis and represses apoptosis in melanoma by regulating miR-143-3p/FLOT2 axis. World J Surg Oncol. 2020;18(1):56. doi:10.1186/s12957-020-01832-9
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang H, Yang H, et al. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer. Mol Oncol. 2020;14(3):539–555. doi:10.1002/1878-0261.12629
   PubMed Web of Science ®Google Scholar
• Huo S, Dou D. Circ_0056285 regulates proliferation, apoptosis and glycolysis of osteosarcoma cells via miR-1244/TRIM44 axis. Cancer Manag Res. 2021;13:1257–1270. doi:10.2147/CMAR.S290645
   PubMed Web of Science ®Google Scholar
• Tai G, Zhang M, Liu F. Circ_0000735 enhances the proliferation, metastasis and glycolysis of non-small cell lung cancer by regulating the miR-635/FAM83F axis. Exp Lung Res. 2021;47(3):136–148. doi:10.1080/01902148.2021.1881188
   PubMed Web of Science ®Google Scholar
• Fang K, Chen X, Qiu F, et al. Serum-derived exosomes-mediated circular RNA ARHGAP10 modulates the progression of non-small-cell lung cancer through the miR-638/FAM83F axis. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2019.3534
   Web of Science ®Google Scholar
• Ding C, Xi G, Wang G, et al. Exosomal Circ-MEMO1 promotes the progression and aerobic glycolysis of non-small cell lung cancer through targeting MiR-101-3p/KRAS axis. Front Genet. 2020;11:962. doi:10.3389/fgene.2020.00962
   PubMed Web of Science ®Google Scholar
• Wang B, Lu Y, Feng E. hsa_circ_0001610 knockdown modulates miR-646-STAT3 axis to suppress endometrial carcinoma progression. J Gene Med. 2021:e3337.
   PubMed Web of Science ®Google Scholar
• Lu X, Gan Q, Gan C. Circular RNA circSEC24A promotes cutaneous squamous cell carcinoma progression by regulating miR-1193/MAP3K9 axis. Onco Targets Ther. 2021;14:653–666. doi:10.2147/OTT.S275691
   PubMed Web of Science ®Google Scholar
• Ma L, Li H, Lin Y, et al. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis. J Surg Res. 2021;260:64–75. doi:10.1016/j.jss.2020.11.052
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhang Y, Meng Q, et al. Hypoxia-induced circular RNA has_circRNA_403658 promotes bladder cancer cell growth through activation of LDHA. Am J Transl Res. 2019;11(11):6838–6849.
   PubMed Web of Science ®Google Scholar
• Jin C, Dong D, Yang Z, et al. CircMYC regulates glycolysis and cell proliferation in melanoma. Cell Biochem Biophys. 2020;78(1):77–88. doi:10.1007/s12013-019-00895-0
   PubMed Web of Science ®Google Scholar
• Li Y, Zang H, Zhang X, et al. circ_0136666 facilitates the progression of colorectal cancer via miR-383/CREB1 axis. Cancer Manag Res. 2020;12:6795–6806. doi:10.2147/CMAR.S251952
   PubMed Web of Science ®Google Scholar
• Zhang Y, Tang K, Chen L, et al. Exosomal CircGDI2 suppresses oral squamous cell carcinoma progression through the regulation of MiR-424-5p/SCAI axis. Cancer Manag Res. 2020;12:7501–7514. doi:10.2147/CMAR.S255687
   PubMed Web of Science ®Google Scholar
• Ju C, Zhou J, Miao H, et al. Bupivacaine suppresses the progression of gastric cancer through regulating circ_0000376/miR-145-5p axis. BMC Anesthesiol. 2020;20(1):275. doi:10.1186/s12871-020-01179-4
   PubMed Web of Science ®Google Scholar
• Wu M, Sun T, Xing L. Circ_0004913 inhibits cell growth, metastasis, and glycolysis by absorbing miR-184 to regulate HAMP in Hepatocellular Carcinoma. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2020.3779
   Web of Science ®Google Scholar
• Zhang X, Li J, Feng Q. CircRNA circYY1 (hsa_circ_0101187) modulates cell glycolysis and malignancy through regulating YY1 expression by sponging miR-769-3p in breast cancer. Cancer Manag Res. 2021;13:1145–1158. doi:10.2147/CMAR.S289172
   PubMed Web of Science ®Google Scholar
• Dong C, Fan B, Ren Z, et al. CircSMARCA5 facilitates the progression of prostate cancer through miR-432/PDCD10 axis. Cancer Biother Radiopharm. 2021;36(1):70–83. doi:10.1089/cbr.2019.3490
   PubMed Web of Science ®Google Scholar
• Liu Y, Chen G, Wang B, et al. Silencing circRNA protein kinase C iota (circ-PRKCI) suppresses cell progression and glycolysis of human papillary thyroid cancer through circ-PRKCI/miR-335/E2F3 ceRNA axis. Endocr J. 2021. doi:10.1507/endocrj.EJ20-0726
   Web of Science ®Google Scholar
• Wang L, Li H, Qiao Q, et al. Circular RNA circSEMA5A promotes bladder cancer progression by upregulating ENO1 and SEMA5A expression. Aging (Albany NY). 2020;12(21):21674–21686. doi:10.18632/aging.103971
   PubMedGoogle Scholar
• Liu J, Liu H, Zeng Q, et al. Circular RNA circ-MAT2B facilitates glycolysis and growth of gastric cancer through regulating the miR-515-5p/HIF-1α axis. Cancer Cell Int. 2020;20(1):171. doi:10.1186/s12935-020-01256-1
   PubMed Web of Science ®Google Scholar
• Chen Z, Wang F, Xiong Y, et al. CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression. Cancer Cell Int. 2020;20(1):400. doi:10.1186/s12935-020-01492-5
   PubMed Web of Science ®Google Scholar
• Guan Y, Cao Z, Du J, et al. Circular RNA circPITX1 knockdown inhibits glycolysis to enhance radiosensitivity of glioma cells by miR-329-3p/NEK2 axis. Cancer Cell Int. 2020;20(1):80. doi:10.1186/s12935-020-01169-z
   PubMed Web of Science ®Google Scholar
• Yue L, Wang G, Zhu M. CircRNA SEPT9 contributes to malignant behaviors of glioma cells via miR-432-5p-mediated regulation of LASP1. Brain Res. 2021;1766:147501. doi:10.1016/j.brainres.2021.147501
   PubMed Web of Science ®Google Scholar
• Liu A, Xu J. Circ_03955 promotes pancreatic cancer tumorigenesis and Warburg effect by targeting the miR-3662/HIF-1α axis. Clin Transl Oncol. 2021. doi:10.1007/s12094-021-02599-5
   Web of Science ®Google Scholar
• Xu Y, Jiang T, Wu C, et al. CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p/STAT3 to inhibit cisplatin sensitivity. Biotechnol Lett. 2020;42(7):1123–1135. doi:10.1007/s10529-020-02846-9
   PubMed Web of Science ®Google Scholar
• Shangguan H, Feng H, Lv D, et al. Circular RNA circSLC25A16 contributes to the glycolysis of non-small-cell lung cancer through epigenetic modification. Cell Death Dis. 2020;11(6):437. doi:10.1038/s41419-020-2635-5
   PubMed Web of Science ®Google Scholar
• Liu Z, Wang R, Zhu G. Circ_0035483 functions as a tumor promoter in renal cell carcinoma via the miR-31-5p-Mediated HMGA1 upregulation. Cancer Manag Res. 2021;13:693–706. doi:10.2147/CMAR.S282806
   PubMed Web of Science ®Google Scholar
• Lin L, Li N, Hu X, et al. Identification of circ_0085616 as an Upregulated and Oncogenic Circular RNA in Cervical Cancer Via the miR-503-5p-Mediated ATXN7L3 Activation. Cancer Biother Radiopharm. 2020. doi:10.1089/cbr.2020.3865
   Web of Science ®Google Scholar
• Gao Y, Ma H, Gao Y, et al. CircRNA Circ_0001721 Promotes the Progression of Osteosarcoma Through miR-372-3p/MAPK7 Axis. Cancer Manag Res. 2020;12:8287–8302. doi:10.2147/CMAR.S244527
   PubMed Web of Science ®Google Scholar
• He S, Yang J, Jiang S, et al. Circular RNA circ_0000517 regulates hepatocellular carcinoma development via miR-326/IGF1R axis. Cancer Cell Int. 2020;20(1):404. doi:10.1186/s12935-020-01496-1
   PubMed Web of Science ®Google Scholar